GSK launches Gate2Health: science, technology, and collaboration to transform healthcare

GSK introduces an open innovation community bringing together more than 10 entities to develop solutions for healthcare system challenges, with a special focus on women's health and prevention.

The search for answers to unmet patient needs requires bringing together different perspectives. With that goal in mind, GSK has introduced Gate2Health in Madrid, an open innovation community that connects healthcare professionals, patient associations, technology companies, startups, and other organizations committed to transforming healthcare.

Three challenges to drive new solutions

Diagnóstico más temprano del lupus

La variabilidad de sus síntomas y su posible confusión con otras enfermedades pueden retrasar la identificación de esta patología, que afecta especialmente a las mujeres. Gate2Health busca promover soluciones que contribuyan a detectar antes la enfermedad.1,2

Abordaje integral del asma grave

Además de sus efectos respiratorios, la enfermedad puede asociarse a ansiedad y depresión, con repercusión en la calidad de vida.3 La iniciativa pretende explorar respuestas que integren también el bienestar emocional de las pacientes.

Vacunación en adultos

Mejorar la información y facilitar el acceso a la vacunación son desafíos relevantes para la prevención. La comunidad trabajará en tecnologías y estrategias innovadoras que ayuden a superar barreras y reforzar la cobertura vacunal.

A community built on collaboration

Gate2Health brings together healthcare, scientific, technological, and social entities—including HM Hospitales, Tecnalia, ITEMAS, Microsoft, Telefónica, scientific societies, and patient organizations. The initiative aims to identify real-world needs, validate opportunities, and co-create solutions to improve the patient journey through more efficient and participatory care.

“We are proud to put innovation at the service of patients and work hand in hand with other organizations to find solutions that continue to improve people's lives”.

Cristina Henríquez de Luna,

president of GSK Spain

With Gate2Health, GSK aims to turn collaboration across science, technology, and talent into solutions that address concrete needs, placing the patient at the center and reinforcing prevention as well as the transformation of women's health.

References:

  1. Felten R, Sagez F, Gavand PE, et al. 10 most important contemporary challenges in the management of SLE. Lupus Sci Med. 2019 Jan 10;6(1):e000303.

  2. Kernder A, Richter JG, Fischer-Betz R, et al. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort. Lupus. 2021 Mar;30(3):431-438.

  3. Stubbs MA, Clark VL, Gibson PG, et al. Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma. Respir Res. 2022 Dec 12;23(1):341.